Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Supplementary material for the financial results for the first quarter of the year ending March 31, 2026
Consolidated Financial Results for the Three Months Ended June 30, 2025 (Based on Japanese GAAP)
TOWA PHARMA, Apr-Jun (1Q) Ordinary Profit Decreases by 54%
Notice of a Fire at Part of the First Solid Dosage Building at Our Yamagata Plant (Third Report)
Notice of a Fire at Part of the First Solid Dosage Building at Our Yamagata Plant (Second Report)
Notice of a Fire at Part of the First Solid Dosage Building at Our Yamagata Plant
Notice of Completion of Payment for Disposal of Treasury Shares as Restricted Stock Compensation
Notice of Financial Results of Parent Company, etc.
Matters Related to Controlling Shareholders
Notice of Disposal of Treasury Shares as Restricted Stock Compensation
Notice of Changes in Officers
Supplementary material for the financial results for the year ended March 31, 2025
Notice of Revisions of Financial Objectives of the 6th Medium-term Business Plan (2024-2026) PROACTIVE III
Supplementary material for the financial results for the year ended March 31, 2025
Supplementary material for the financial results for the year ended March 31, 2025
Notice of Revisions of Financial Objectives of the 6th Medium-term Business Plan (2024-2026) PROACTIVE III
Notice of Revisions of Financial Objectives of the 6th Medium-term Business Plan (2024-2026) PROACTIVE III
Notice of Revisions of Financial Objectives of the 6th Medium-term Business Plan (2024-2026) PROACTIVE III
Notice of Revisions of Financial Objectives of the 6th Medium-term Business Plan (2024-2026) PROACTIVE III
Supplementary material for the financial results for the year ended March 31, 2025